How to use novel antimicrobials beyond official indications: an expert consensus

This consensus supports the judicious off-label use of new antimicrobials in specific clinical scenarios where therapeutic gaps exist. The guidance prioritizes targeted treatment over empirical use, aligning with international ASP principles and WHO recommendations. These results provide a regional reference to optimize ASP initiatives focus on new antibiotic use while minimizing ecological impact and resistance development.

Authors

Institutions

Publication Details

Journal
JAC-Antimicrobial Resistance
Published
2025-10-03
DOI
https://doi.org/10.1093/jacamr/dlaf184
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

How to use novel antimicrobials beyond official indications: an expert consensus

Julia Praena‐Segovia, Ignacio Márquez-Gómez, Andrés Martín-Aspas, M Ángeles Esteban-Moreno et al.
JAC-Antimicrobial Resistance
Pharmaceutical studies and practices
article

How to use novel antimicrobials beyond official indications: an expert consensus

Julia Praena‐Segovia, Ignacio Márquez-Gómez, Andrés Martín-Aspas, M Ángeles Esteban-Moreno, Svetlana Sadyrbaeva-Dolgova, Juan E. Corzo-Delgado, Lucía Valiente de Santis, Patricia Jiménez-Aguilar, Pilar Retamar, Salvador López-Cárdenas, Juan José Castón-Osorio, Jesús Rodríguez‐Baño, Francisco Javier Martínez‐Marcos, Zaira R. Palacios‐Baena, Francisco Anguita-Santos, Guillermo Ojeda, Carmen Herrero‐Rodríguez, María Alegre-Albendea
article en

Abstract

This consensus supports the judicious off-label use of new antimicrobials in specific clinical scenarios where therapeutic gaps exist. The guidance prioritizes targeted treatment over empirical use, aligning with international ASP principles and WHO recommendations. These results provide a regional reference to optimize ASP initiatives focus on new antibiotic use while minimizing ecological impact and resistance development.

JAC-Antimicrobial ResistanceVol. 7(6)
Universidad de La Frontera (CL), Instituto de Salud Carlos III (ES), Hospital Universitario Virgen Macarena (ES), Instituto Maimónides de Investigación Biomédica de Córdoba (ES), Hospital Regional Universitario de Málaga (ES), Instituto de Investigación Biosanitaria de Granada (ES), Hospital Universitario Virgen de las Nieves (ES), Complejo Hospitalario de Jaén (ES), Biomedical Research and Innovation Institute of Cadiz (ES), Hospital Juan Ramón Jiménez (ES), Instituto de Biomedicina de Sevilla (ES), Hospital Universitario Puerto Real (ES), Hospital Universitario de Valme (ES), Complejo Hospitalario Torrecárdenas (ES), Hospital Jerez Puerta del Sur (ES), Hospital Clínico Universitario Virgen de la Victoria (ES)
Openalex Percentile: Top 53%
Pharmaceutical studies and practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.